Log in

NASDAQ:RCM - R1 RCM Stock Price, Forecast & News

$12.13
-0.35 (-2.80 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$12.11
Now: $12.13
$12.54
50-Day Range
$10.19
MA: $12.02
$12.95
52-Week Range
$7.10
Now: $12.13
$13.19
Volume1.57 million shs
Average Volume1.01 million shs
Market Capitalization$1.37 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.18
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. Read More…

Industry, Sector and Symbol

Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Current SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$868.50 million
Cash Flow$0.23 per share
Book Value$0.06 per share

Profitability

Net Income$-45,300,000.00

Miscellaneous

Employees18,600
Market Cap$1.37 billion
Next Earnings Date2/28/2020 (Estimated)
OptionableNot Optionable

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.


R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) posted its earnings results on Tuesday, November, 5th. The healthcare provider reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.09 by $0.08. The healthcare provider had revenue of $301.20 million for the quarter, compared to analyst estimates of $302.85 million. R1 RCM had a positive return on equity of 100.31% and a negative net margin of 0.13%. The firm's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period last year, the company posted ($0.17) EPS. View R1 RCM's Earnings History.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for R1 RCM.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM issued an update on its FY 2019 earnings guidance on Tuesday, September, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.175-1.2 billion, compared to the consensus revenue estimate of $1.23 billion.

What price target have analysts set for RCM?

3 analysts have issued 1-year price targets for R1 RCM's shares. Their forecasts range from $10.00 to $14.00. On average, they anticipate R1 RCM's stock price to reach $12.33 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View Analyst Price Targets for R1 RCM.

What is the consensus analysts' recommendation for R1 RCM?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.

Has R1 RCM been receiving favorable news coverage?

News headlines about RCM stock have been trending somewhat negative recently, InfoTrie reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. R1 RCM earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned media headlines about the healthcare provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for R1 RCM.

Are investors shorting R1 RCM?

R1 RCM saw a decline in short interest in November. As of November 15th, there was short interest totalling 6,590,000 shares, a decline of 6.7% from the October 31st total of 7,060,000 shares. Based on an average trading volume of 1,070,000 shares, the short-interest ratio is currently 6.2 days. Currently, 6.8% of the company's stock are short sold. View R1 RCM's Current Options Chain.

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:
  • Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
  • Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
  • Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
  • Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman, Exec. VP of Compliance & Risk

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by a number of of institutional and retail investors. Top institutional investors include Endurant Capital Management LP (2.11%), State Street Corp (1.95%), Voya Investment Management LLC (1.49%), Castleark Management LLC (0.66%), Man Group plc (0.65%) and Russell Investments Group Ltd. (0.58%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.

Which institutional investors are selling R1 RCM stock?

RCM stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Point72 Asset Management L.P., Gilder Gagnon Howe & Co. LLC, Voya Investment Management LLC, State Street Corp, P.A.W. Capital Corp, Cadence Capital Management LLC and Hennessy Advisors Inc.. View Insider Buying and Selling for R1 RCM.

Which institutional investors are buying R1 RCM stock?

RCM stock was bought by a variety of institutional investors in the last quarter, including Endurant Capital Management LP, Man Group plc, Eagle Asset Management Inc., Mackay Shields LLC, State of New Jersey Common Pension Fund D, Barclays PLC, California Public Employees Retirement System and Alberta Investment Management Corp. View Insider Buying and Selling for R1 RCM.

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $12.13.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $1.37 billion and generates $868.50 million in revenue each year. The healthcare provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.

What is R1 RCM's official website?

The official website for R1 RCM is http://www.r1rcm.com/.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]


MarketBeat Community Rating for R1 RCM (NASDAQ RCM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  196 (Vote Outperform)
Underperform Votes:  272 (Vote Underperform)
Total Votes:  468
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel